title: Differential regulation of chromogranin B/secretogranin I and secretogranin II by forskolin in PC12 cells.
abstract: The factors which regulate the expression of the granin family of secretory proteins have yet to be completely described. The present study investigated the effects of forskolin (FSK), an activator of adenylate cyclase, on the regulation of chromogranin B/secretogranin I (CgB) and secretogranin II (SgII) mRNA levels in rat PC12 cells. PC12 cells were treated with 10 microM FSK for time points up to 48 h and were harvested for cAMP determination, RNA isolation and Northern blot analysis, or fixed in 4% paraformaldehyde for immunocytochemistry. Cellular cAMP levels peaked after two h of FSK treatment and remained elevated for 48 h. Chromogranin B mRNA increased with FSK treatment, reaching a maximum of 7-fold above control after 24 h, while the level of SgII mRNA decreased to a level of 65 +/- 10% of control after 48 h. The effects of FSK on CgB mRNA appear to be mediated by cAMP, as 8-bromo-cAMP (500 microM) resulted in a 2.8-fold increase in CgB mRNA, and H-89 (30 microM), a selective inhibitor of cAMP-dependent protein kinase, reduced the FSK-mediated response. The level of CgB was also increased in FSK-treated cells, as evidenced by immunofluorescent analysis which showed a more intense staining in PC12 cells treated with FSK for 48 h than in untreated cells. The intensity of SgII staining was diminished by FSK treatment, most likely a result of a decreased rate of synthesis as well as an increase in the release of SgII. This study demonstrated that the mRNA and protein levels of CgB and SgII are differentially regulated by cAMP in PC12 cells.
authors.affiliation: Department of Pharmacology, University of South Alabama, Mobile 36688.
authors.forename: M E
authors.initials: ME
authors.lastname: Thompson
authors.forename: W E
authors.initials: WE
authors.lastname: Zimmer
authors.forename: L B
authors.initials: LB
authors.lastname: Wear
authors.forename: L A
authors.initials: LA
authors.lastname: MacMillan
authors.forename: W J
authors.initials: WJ
authors.lastname: Thompson
authors.forename: W B
authors.initials: WB
authors.lastname: Huttner
authors.forename: H
authors.initials: H
authors.lastname: Hidaka
authors.forename: J G
authors.initials: JG
authors.lastname: Scammell
mesh_terms: D000591:Amino Acid Isomerases / Q000235:genetics / Q000378:metabolism; D000818:Animals; D015152:Blotting, Northern; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism; D053378:Chromogranin B; D002864:Chromogranins; D005576:Colforsin / Q000494:pharmacology*; D000242:Cyclic AMP / Q000378:metabolism; D015342:DNA Probes; D015870:Gene Expression / Q000187:drug effects; D007150:Immunohistochemistry; D016716:PC12 Cells; D019696:Peptidylprolyl Isomerase; D011189:Potassium Chloride / Q000494:pharmacology; D011506:Proteins / Q000032:analysis / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism*
chemical_list: D002352:Carrier Proteins; D053378:Chromogranin B; D002864:Chromogranins; D015342:DNA Probes; D011506:Proteins; D012333:RNA, Messenger; C506140:chromogranin B, rat; D005576:Colforsin; D011189:Potassium Chloride; D000242:Cyclic AMP; D000591:Amino Acid Isomerases; D019696:Peptidylprolyl Isomerase